Comments
Loading...

BioCryst Pharma

BCRXNASDAQ
Logo brought to you by Benzinga Data
$9.21
-0.18-1.92%
At close: -
$9.25
0.040.43%
After Hours: 4:28 PM EDT
Q4 2024 earnings tomorrow on Mon Feb 24th before the market open
Conference call scheduled tomorrow at 8:30 AM Click to view the webcast

BioCryst Pharma (NASDAQ:BCRX) Stock, Earnings Estimates, EPS, And Revenue

BioCryst Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 24
EPS Estimate
$-0.060
Quarterly Revenue Estimate
$127.72M
Annual Revenue
(as of Sep 30)
$412.58M

Analyze the earnings history of BioCryst Pharma using advanced sorting and filters.

Data brought to you by Benzinga APIs

BioCryst Pharma (BCRX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32024-11-04$-0.07$-0.06-16.7 %
Q22024-08-05$-0.06$-0.1764.7 %
Q12024-05-06$-0.17$-0.2119.1 %
Q42024-02-26$-0.28$-0.24-16.7 %

BioCryst Pharma (BCRX) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32024-11-04$117.09M$112.50M4.08 %
Q22024-08-05$109.33M$98.47M11.0 %
Q12024-05-06$92.76M$85.60M8.37 %
Q42024-02-26$93.40M$90.01M3.77 %

FAQ

Q

When is BioCryst Pharma (NASDAQ:BCRX) reporting earnings?

A

BioCryst Pharma (BCRX) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for BioCryst Pharma (NASDAQ:BCRX)?

A

The Actual EPS was $-0.07, which missed the estimate of $-0.06.

Q

What were BioCryst Pharma’s (NASDAQ:BCRX) revenues?

A

The Actual Revenue was $117.1M, which beat the estimate of $112.5M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch